DRUG · Mapped RxNorm record
Glycopyrronium
Normalized identity: glycopyrroniumView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD
NCT01959516
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Tiotropium
Normalized identity: tiotropiumView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo to glycopyrronium
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo to tiotropium
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
GlycopyrroniumDRUG · verified · RxNorm: glycopyrronium
TiotropiumDRUG · verified · RxNorm: tiotropium
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01959516 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.